Lot Riding On IGI’s Promising Trispecific Antibody For Myeloma

 
• By Anju Ghangurde
  
Cyril Konto, President and CEO, Ichnos Glenmark Innovation, • Source: Ichnos Glenmark Innovation

More from Clinical Trials

More from Therapy Areas